← Evidence map

RetractedArticleNaunyn-Schmiedeberg's archives of pharmacology2025

UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Jing Bao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39085511